Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kyntra Bio (KYNB) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to -$2.6.

  • Kyntra Bio's Times Interest Earned rose 8873.05% to -$2.6 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.24, marking a year-over-year increase of 9204.46%. This contributed to the annual value of -$18.24 for FY2024, which is 5425.04% up from last year.
  • Latest data reveals that Kyntra Bio reported Times Interest Earned of -$2.6 as of Q3 2025, which was up 8873.05% from -$6.0 recorded in Q2 2025.
  • Kyntra Bio's 5-year Times Interest Earned high stood at $467.65 for Q3 2021, and its period low was -$1229.5 during Q4 2021.
  • For the 5-year period, Kyntra Bio's Times Interest Earned averaged around -$198.56, with its median value being -$24.84 (2024).
  • Data for Kyntra Bio's Times Interest Earned shows a peak YoY increase of 73896.63% (in 2021) and a maximum YoY decrease of 104047.28% (in 2021) over the last 5 years.
  • Over the past 5 years, Kyntra Bio's Times Interest Earned (Quarter) stood at -$1229.5 in 2021, then surged by 95.19% to -$59.12 in 2022, then soared by 167.91% to $40.14 in 2023, then crashed by 108.01% to -$3.22 in 2024, then grew by 19.22% to -$2.6 in 2025.
  • Its Times Interest Earned stands at -$2.6 for Q3 2025, versus -$6.0 for Q2 2025 and -$4.97 for Q1 2025.